Allogeneic Second-generation CD19-CAR T Cells for Pediatric Relapsed/Refractory B-ALL

Clinical trial NCT06080191 · RECRUITING

Trial details

NCT number: NCT06080191
Sponsor: Bambino Gesù Hospital and Research Institute
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Acute Lymphoblastic Leukemia

Start date: 2024-04-28
Primary completion: 2026-06-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.